Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase II randomized double-blind placebo-controlled study of VC005 tablets in non-segmental vitiligo
CTR20253528Phase 2Active
- Sponsor
- Jiangsu Vcare PharmaTech Co., Ltd.
- Start
- Oct 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of VC-005 in Vitiligo, sponsored by Jiangsu Vcare PharmaTech Co., Ltd.. Started Oct 2025; status: active.
02
Drugs
VC-005
03
Conditions
Vitiligo
Beyond the preview
Go deeper on CTR20253528.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20253528.